Vosoghinia H,Esmaeilzadeh A,Ganji A,Hosseini SM,Jamehdar SA,Salehi M .2016 .Vitamin D in standard HCV regimen (PEGinterferon plus ribavirin), its effect on the early virologic response rate: a clinical trial. Razavi Int J Med, 4(2) : .
Loftfield E,O'Brien TR,Pfeiffer RM,Howell CD,Horst R,ProkuninaOlsson L,VIRAHEP-C Trials L .2016 .Vitamin D status and virologic response to HCV therapy in the HALT-C and. , 11(11) : e0166036.
Ali SA,Donahue RM,Qureshi H,Vermund SH .2009 .Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infec Dis, 13(1) : 9-19.
.2016 .Sofosbuvir treatment and hepatitis C virus infection. World J Hepatol, 8(3) : 183.
Feldman M,Friedman LS,Brandt LJ,Consult Premium Edition-Enhanced Online Expert .2010 .Sleisenger and Fordtran's Gastrointestinal and Liver Disease. , : .
Mahon BD,Wittke A,Weaver V,Cantorna MT .2003 .The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cellular Biochem, 89(5) : 922-32.
Abu-Mouch S,Fireman Z,Jarchovsky J,Zeina AR,Assy N. .2011 .Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. WJG, 17(47) : 5184.
Arteh J,Narra S,Nair S. .2010 .Prevalence of vitamin D deficiency in chronic liver disease. Digestive Dis Sci, 55(9) : 2624-8.
Petta S,Camma C,Scazzone C,Tripodo C,Di Marco V,Bono A .2010 .Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C. Hepatology, 51(4) : 1158-67.
Southern PB,El Sayed P,Fenton L,Forrester K,Moreea S. Influence Of Vitamin D Supplementation K .2010 .On Outcome In The Treatment Of Chronic Hepatitis C. Hepatology, 52 : 807A-8.
Thanapirom K,Suksawatamnuay S,Sukeepaisarnjaroen W,Tangkijvanich P,Treeprasertsuk S,Thaimai P .2017 .Vitamin Drelated gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol, 17(1) : 54.
.2014 .American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Recommendations for testing, managing. , : .
JM Pawlotsky .2014 .New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology, 146(5) : 1176-92.
Sabry D,Al-Ghussein MA,Hamdy G,Abul-Fotouh A,Motawi T,El Kazaz AY . .Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients. , : .
.2015 .. Therapeutics Clin Risk Management, 11 : 279.
Vitamin .2015 .D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. WJG, 21(18) : 5647.
J Hepatol .2014 .. , 61(6) : 1247-52.
Jiménez-Sousa MA,Rallón N,Berenguer J,Pineda-Tenor D,López JC,Soriano V .2015 .TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. J Clin Virol, 65 : 62-7.
Luo Y-q,Xiang C .2014 .Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B, 15(10) : 900-6.